Soleno Therapeutics Inc. buy Laidlaw
Start price
27.03.25
/
50%
€61.65
Target price
27.03.26
€97.53
Performance (%)
-58.18%
End price
28.03.26
€25.78
Summary
This prediction ended on 28.03.26 with a price of €25.78. The BUY prediction by Laidlaw for Soleno Therapeutics Inc. performed very badly with a performance of -58.18%. Laidlaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Soleno Therapeutics Inc. | -0.045% | -0.045% | -25.776% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Laidlaw for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
In the thread Trading Soleno Therapeutics Inc.
Die von Laidlaw gewählte maximale Laufzeit wurde überschritten